Correlation Between Shuttle Pharmaceuticals and Sonoma Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Sonoma Pharmaceuticals.

Diversification Opportunities for Shuttle Pharmaceuticals and Sonoma Pharmaceuticals

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Shuttle and Sonoma is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Sonoma Pharmaceuticals go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and Sonoma Pharmaceuticals

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the Sonoma Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Shuttle Pharmaceuticals is 1.65 times less risky than Sonoma Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The Sonoma Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  2,200  in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (1,907) from holding Sonoma Pharmaceuticals or give up 86.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Shuttle Pharmaceuticals  vs.  Sonoma Pharmaceuticals

 Performance 
       Timeline  
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sonoma Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sonoma Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Shuttle Pharmaceuticals and Sonoma Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shuttle Pharmaceuticals and Sonoma Pharmaceuticals

The main advantage of trading using opposite Shuttle Pharmaceuticals and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.
The idea behind Shuttle Pharmaceuticals and Sonoma Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon